US · RBOT
Vicarious Surgical Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Waltham, MA 02451
- Website
- vicarioussurgical.com
Price · as of 2024-12-31
—
Market cap 13.19M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $301.20 | ||||
| 2021 | $159.90 | ||||
| 2022 | $67.20 | ||||
| 2023 | $10.65 | ||||
| 2024 | $9.30 |
AI valuation
Our deep-learning model estimates Vicarious Surgical Inc.'s (RBOT) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| RBOT | Vicarious Surgical Inc. | $2.04 | 13.19M | — | — | — | — | -0.87 | 1.17 | — | -0.32 | — | 1.17 | 0.00% | — | — | -87.40% | -511.76% | -67.41% | 0.30 | — | 6.74 | 6.40 | -0.07 | -2658.00% | — | -2163.00% | -91.59% | -6.52 | -385.51% | 0.00% | 0.00% | 0.00% | -0.29 | -0.39 | — | -4.95 |
| BOLD | Boundless Bio, Inc. | $1.16 | 25.97M | — | — | — | — | -0.44 | 0.19 | — | 1.18 | -0.60 | 0.19 | 0.00% | — | — | -554.86% | 73.46% | -38.87% | 0.32 | — | 18.98 | 18.70 | -0.33 | 7342.00% | — | 3346.00% | -220.80% | -7.48 | 63.54% | 0.00% | 0.00% | 0.00% | 1.03 | 1.20 | — | -1.38 |
| HYPD | Hyperion DeFi, Inc. | $2.82 | 16.06M | +1,294% | +147,433% | — | — | -0.03 | -0.10 | 23.10 | -0.23 | -0.21 | -0.10 | -6749.50% | -85004.58% | -86888.57% | 2432.03% | -1558.51% | -307.07% | -0.86 | -19.62 | 0.17 | 0.13 | -0.20 | 1253.00% | 141402.00% | 890.00% | -2286.39% | -1.88 | -968.35% | 0.00% | 0.00% | 0.00% | -0.21 | -0.34 | 182.16 | -122.68 |
| INTS | Intensity Therapeutics, I… | $7.66 | 14.45M | — | — | — | — | -1.89 | 10.53 | — | -1.74 | — | 10.53 | 0.00% | — | — | -202.34% | 3350.51% | -147.37% | 0.05 | — | 1.92 | 1.48 | 0.15 | -1522.00% | — | 11124.00% | -49.52% | -8.67 | 3074.75% | 0.00% | 0.00% | 0.00% | -1.71 | -1.86 | — | -20.70 |
| ITRM | Iterum Therapeutics plc | $0.26 | 13.97M | — | — | — | — | -1.10 | -6.66 | — | -2.24 | — | -1.14 | 0.00% | — | — | 472.61% | -628.33% | -69.93% | -11.16 | — | 1.41 | 1.37 | -0.99 | -5743.00% | — | -3195.00% | -98.48% | -1.52 | -899.75% | 0.00% | 0.00% | 0.00% | -2.60 | -1.82 | — | -16.11 |
| MODD | Modular Medical, Inc. | $0.25 | 15.64M | — | — | — | — | -1.66 | 1.83 | — | -1.09 | — | 1.83 | 0.00% | — | — | -131.58% | -459.49% | -115.69% | 0.05 | — | 10.69 | 10.41 | 0.71 | -3462.00% | — | 1636.00% | -58.31% | -12.43 | -439.34% | 0.00% | 0.00% | 13.57% | -1.00 | -1.04 | — | 2.40 |
| NXL | Nexalin Technology, Inc. | $0.47 | 8.77M | +5,717% | +102% | — | — | -2.88 | 5.97 | 130.00 | -2.38 | -9.08 | 6.42 | 78.31% | -4596.14% | -4508.73% | -221.05% | -3380.55% | -193.70% | 0.00 | — | 7.25 | 6.39 | 0.07 | 3175.00% | 5235.00% | -1.00% | -17.98% | -7.21 | -1719.51% | 0.00% | 0.00% | 0.00% | -2.38 | -4.68 | 109.37 | -9.04 |
| PIII | P3 Health Partners Inc. | $2.12 | 6.93M | +1,116% | +75% | — | — | -0.09 | 0.35 | 0.02 | -0.78 | -0.11 | -0.05 | 100.00% | -21.37% | -9.05% | -284.66% | -147.86% | -37.75% | 2.19 | -14.46 | 0.37 | 0.33 | -0.64 | 7758.00% | 1848.00% | 4145.00% | -409.98% | -0.22 | -50.78% | 0.00% | 0.00% | 0.00% | -0.48 | -1.40 | 0.10 | -0.79 |
| PSTV | Plus Therapeutics, Inc. | $0.30 | 18.31M | +20,855% | +1,192% | — | — | -0.80 | -1.16 | 1.79 | -1.21 | — | -1.06 | 85.37% | -252.32% | -222.84% | 252.07% | 197.13% | -144.03% | -0.38 | -3.95 | 0.34 | 0.27 | -0.39 | -4481.00% | 1854.00% | -1776.00% | -102.64% | -0.68 | 143.54% | 0.00% | 0.00% | 3.59% | -0.69 | -0.95 | 1.75 | -112.05 |
| QTTB | Q32 Bio Inc. | $4.56 | 56.11M | +726% | — | — | — | -0.57 | 4.77 | — | 0.71 | — | 4.77 | 0.00% | — | — | 53.86% | 62.63% | -68.49% | 3.33 | -220.34 | 4.97 | 4.77 | 1.30 | -6060.00% | -10000.00% | 26286.00% | -250.34% | -4.11 | 64.23% | 0.00% | 0.00% | 311.27% | 0.48 | 0.47 | — | -4.89 |
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
- CEO
- Stephen From
- Employees
- 123
- Beta
- 1.55
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ —) − 1 = — (DCF, example).